Form4insider filings, from the source

SEC Form 4 · accession 0001181431-15-008492

SUPERNUS PHARMACEUTICALS, INC. · SUPN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
M James Barrett
Director · 10% Owner
Period of report
Jun 17, 2015
Accepted (ET)
Jun 19, 2015 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF6,F5Jun 17, 2015S63,085$16.6728D48,796ISee Note 5
Common StockF7,F5Jun 17, 2015S48,796$16.0218D0ISee Note 5
Common StockF1holding———7,641,250ISee Note 1
Common Stockholding———32,524D
Common StockF2holding———16,262ISee Note 2
Common StockF3holding———9,406ISee Note 3
Common StockF4holding———6,856ISee Note 4

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses